AKT1 and triple-negative breast carcinoma: Because reduced AKT3 expression levels in triple-negative breast cancers are reported to increase sensitivity to GSK690693 (Chin et al., 2014), FPKM values of AKT1/2/3 were checked in GUMC220/221.